LSTA — Lisata Therapeutics, Inc.

LSTALisata Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · lisata.com

3.230USD+2.87%Mkt Cap: 29.41M USDP/E: —Last update: 2026-05-26

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational prod…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap29.41M USD

Enterprise Value15.28M USD

Revenue (TTM)170.00K USD

Gross Profit170.00K USD

Net Income (TTM)-16.59M USD

Revenue/Share0.0190 USD

Last Price3.230 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees21

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-2.71

PEG118.40

EV/EBITDA-0.89

EV/Revenue89.88

P/S168.20

P/B2.62

EPS (TTM)-1.86

EPS (Forward)-1.16

52W Range

1.81044% of range5.070

52W High5.070 USD

52W Low1.810 USD

Profitability

Gross Margin100.00%

Oper. Margin-10178.82%

EBITDA Margin0.00%

Profit Margin-9756.47%

ROE-111.65%

ROA-93.47%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-15.95M USD

CapEx (TTM)28.00K USD

FCF Margin-4740.59%

FCF Yield-27.40%

Net Debt-13.06M USD

Net Debt/EBITDA0.76

Balance Sheet

Debt/Equity0.00

Current Ratio4.23

Quick Ratio3.94

Book Value/Sh1.200 USD

Cash/Share1.434 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:15

Split DateSep 15, 2022

Analyst Consensus

Rating3.0 (Hold)

Target (Mean)4.000 USD

Target Range4.000 USD – 4.000 USD

# Analysts1

Ownership

Shares Out.9.11M

Float7.19M

Insiders20.89%

Institutions11.43%

Short Interest

Short Ratio0.8d

Short % Float0.93%

Short % Out.0.77%

Shares Short70.25K

Short (prev mo.)16.93K

Technical

SMA 504.041 (-20.1%)

SMA 2003.102 (+4.1%)

Beta—

S&P 52W Chg28.31%

Avg Vol (30d)67.60K

Avg Vol (10d)21.83K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—